leucodin has been researched along with Fatty Liver in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, BW; Jiang, M; Jin, MJ; Jin, Q; Li, X; Li, XF; Li, Y; Lian, LH; Nan, JX; Shang, Y; Wu, YL; Zhang, Y | 1 |
1 other study(ies) available for leucodin and Fatty Liver
| Article | Year |
|---|---|
Leucodin attenuates inflammatory response in macrophages and lipid accumulation in steatotic hepatocytes via P2x7 receptor pathway: A potential role in alcoholic liver disease.
Topics: Adenosine Triphosphate; Animals; Cell Line; Ethanol; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Inflammation; Interleukin-1beta; Lipid Metabolism; Lipopolysaccharides; Liver Diseases, Alcoholic; Macrophages, Peritoneal; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Receptors, Purinergic P2X7; Sesquiterpenes | 2018 |